Novo Nordisk | NVO - Ebit





Ebit تغيير تاريخ
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Aurora Cannabis CAD 7.12M 42.91M 2026-03
Bausch Health Companies USD 776M 287M 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Canopy Growth CAD -145.65M 132.99M 2026-03
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Drreddys Laboratories INR 3.05B 13.32B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.73B 549M 2026-06
Novo Nordisk DKK 59.62B 27.24B 2026-03
Novo Nordisk DKK 5.18B 37.04B 2025-06
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 75.49M 7M 2026-03
Sanofi EUR 1.12B 811M 2026-06
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Zoetis USD 842M 7M 2026-03